Traveling with Medical Marijuana - Legal Guide 2026

Traveling with a drug containing THC is not impossible, but it requires a document that is neither issued by a doctor nor a pharmacy. From July 12, 2026, the procedure will be regulated in Poland by a new regulation of the Minister of Health, which clarifies three things that are often misrepresented in guides: who issues the document, how long it is valid, and how much time before departure one needs to submit the application. This text describes only the Polish side, as only it can be verified in the Polish Journal of Laws. You check the regulations of the destination country with its authorities, and we explain below why there is no shortcut for that. Each regulation is provided with a number so that it can be opened independently.

KEY INFORMATION
- The document for travel to an EU country is issued by the provincial pharmaceutical inspector, and for travel outside the EU by the Chief Pharmaceutical Inspector (§ 5 and § 6 of the regulation) Dz.U. 2026 poz. 827).
- The document is issued for a specified period, not exceeding 30 days.
- The application must be submitted no later than 15 days before the day of crossing the border of the Republic of Poland.
- Transporting narcotic drugs in violation of the provisions of the law is subject to a fine and imprisonment for up to 5 years (Article 55, paragraph 1 of the Act on Counteracting Drug Addiction).
- A Polish document does not replace the consent of the destination country and does not protect against its regulations.

Who issues the document for transporting a drug containing THC across the border?

It depends on the direction of travel, and this is the first thing that guides often confuse. Travel to another EU country is handled by the appropriate provincial pharmaceutical inspector, who issues a document allowing intra-community delivery of narcotic drugs, psychotropic substances, or category 1 precursors for personal medical needs. The basis is § 5 of the regulation of the Minister of Health dated June 8, 2026, published as Dz.U. 2026 poz. 827, effective from July 12, 2026.

Travel outside the EU is handled by a different authority and requires a different document. According to § 6 of the same regulation, the document allowing the import or export of narcotic drugs for personal medical needs is issued by the Chief Pharmaceutical Inspector, upon request from the person who is taking the medicinal product. The application must include a prescription or medical documentation regarding the use of such a product.

The distinction has practical consequences. A patient who submits an application to the provincial inspector before traveling to Turkey or the United States will be addressing the wrong authority for that trip. An application to the Chief Pharmaceutical Inspector before traveling to Spain is the same mistake in the opposite direction. The regulation was issued based on Article 37, paragraph 12 of the Act of July 29, 2005, on Counteracting Drug Addiction, in the consolidated text. Dz.U. 2023 poz. 1939.

What is the difference between traveling to the EU and traveling outside the EU?

The deadlines are identical, but the authority and the name of the document are not. The table below compares what the regulation says about both paths. All entries come from the content of the regulation, not from the practices of offices, which may be described online in conflicting versions.

There are two differences that do not fit in the table. The first concerns attachments: for the non-EU pathway, the regulation explicitly requires that a prescription or medical documentation regarding the use of the product be attached to the application. For the EU pathway, there is no such specification in the regulation, but that does not mean that the authority will not request documents confirming treatment.

The second concerns the form of the document itself. For the non-EU pathway, the regulation describes it in detail, including the color of the paper and required security features, while the electronic copy remains with the issuing authority. For the EU pathway, the regulation refers to the instructions contained in the Executive Committee's decision of December 22, 1994, and provides a template in the attachment. In both cases, we are talking about a paper document that must be carried when crossing the border.

What else does this regulation govern besides the patient's document?

The same regulation governs two completely different matters, and mixing them can lead to misunderstandings. Besides the documents for individuals traveling with medication, described in § 5 and § 6, the act specifies the conditions for issuing permits for the import and export of narcotic drugs and psychotropic substances. The latter concerns entrepreneurs and is issued by the Chief Pharmaceutical Inspector to entities with the appropriate authorization under the law.

The requirements on the company's side are incomparably broader. The application includes, among other things, the international non-proprietary name, a description of the substance with the quantity expressed in grams, and for cannabis flowers other than fiber and extracts from it, additionally the THC content, and for extracts, also the amount of flowers from which they were produced. One application can cover a maximum of six items, and applications for narcotic drugs and psychotropic substances must be submitted separately.

The permit is issued only after verifying that the applicant has the appropriate authorization and that the import will not exceed Poland's annual estimated demand for the substance, published by the International Narcotics Control Board. The document is prepared on paper, in Polish and English, in three copies for import and four for export. The patient does not go through any of these procedures, so the descriptions intended for wholesalers say nothing about their situation.

How long before departure must the application be submitted?

No later than fifteen days before the day of crossing the border of the Republic of Poland. The same deadline applies in § 5 sec. 2 and § 6 sec. 2, regardless of whether you are traveling to the Czech Republic or Japan. This is the latest deadline resulting from the regulation, not a recommended deadline: submitting the application on the fourteenth day before departure is not an organizational delay, but a violation of this deadline.

The information circulating in guides that the procedure takes from two to four weeks or from six to eight weeks does not come from any legal act. The regulation only mentions the deadline for submitting the application and the maximum validity of the document. How long it will actually take to process the case at a specific inspectorate depends on that inspectorate, and this regulation does not govern it.

The practical conclusion is simple. Fifteen days is the lower limit, below which the application is simply late, so when planning a trip, it is worth counting upwards from that point, not downwards. If the deadlines do not align, discussing the procedure with the attending physician regarding travel is more appropriate than attempting to transport medication without documentation. The consequences of the latter path are described later in the text.

How long is the document valid and what does it cover?

The document is issued for a specified period, not exceeding 30 days. The wording is identical in both paragraphs, and it is worth noting its structure: it is neither thirty days counted always from the date of issuance nor thirty days of stay, but a designated period that cannot exceed thirty days. The authority enters this period into the document.

The regulation does not contain any limit expressed in grams. The arithmetic repeated in guides, according to which the daily dose multiplied by thirty gives the maximum allowable amount, has no basis in the content of the regulation. The amount of medication results from what the doctor prescribed, and the method of dosing is a mandatory element of the prescription for narcotic drugs in accordance with the regulation on narcotic drugs, in the consolidated text. Dz.U. 2025 poz. 1678.

The document issued by the Chief Pharmaceutical Inspector has one more feature described directly in the regulation. It is prepared on pink paper, with the security features required for public documents of the third category, specified in attachment no. 3 to the regulation. The electronic copy remains with the issuing authority, so the patient travels with the original paper document, not a scan on their phone.

What to do if the trip lasts longer than thirty days?

It must be acknowledged that one document will not cover this. Both § 5 sec. 2 and § 6 sec. 2 establish a limit of thirty days as the maximum period for which the document is issued, and none of these provisions provides for the extension of an issued document. Therefore, a longer stay must be planned differently, not relying on an extension on-site.

There are essentially two directions, and both require a conversation with the attending physician before departure. The first is the continuation of treatment in the destination country, within its own healthcare system and on its terms, which must be inquired about with the local authorities. The second is changing the therapy for the duration of the trip, which is a therapeutic decision that neither the article nor the seller can make.

It is also worth considering a third option, explicitly named, as it may be the most sensible. If the therapy cannot be interrupted and the destination country does not provide a real path for continuation, changing the direction or timing of the trip is a cheaper option than facing criminal proceedings abroad. Delaying this decision until the last week closes all three options at once, as the deadline for submitting the application for the document will have already passed.

Where does Article 75 of the Schengen Convention come from?

From EU law, and the Polish regulation refers to it directly. Article 75 of the Schengen Executive Convention provides for a certificate enabling the patient to transport narcotic drugs and psychotropic substances, and the form of this certificate was defined by the decision of the Executive Committee of December 22, 1994. The Polish regulation from 2026 was issued precisely to implement this decision, and it mentions this in the reference to its title.

This is where frequent misunderstandings arise. The Schengen certificate is real, but it is not a separate path alongside the Polish procedure. It is the same path: § 5 of the regulation requires the provincial pharmaceutical inspector to issue documents precisely in accordance with the instructions specified in this decision. The template for the document is attachment no. 4 to the regulation.

This is important when seeking information. If a guide refers to the Schengen certificate without indicating the Polish implementing regulation, it describes the treaty framework but does not say to whom and when to submit an application in Poland. These two things must be read together, and the numbers of both acts are sufficient to access the content at the source.

What does a Polish prescription for cannabis flower look like and how long can it be filled?

Cannabis flowers other than fiber can be a pharmaceutical raw material intended for the preparation of prescription medications, based on Article 33a of the Act on Counteracting Drug Addiction, after obtaining permission from the President of the Office for Registration of Medicinal Products. Such permission is issued for a period of five years. The entire path thus goes through the doctor and the pharmacy.

The validity period for prescriptions for narcotic drugs, psychotropic substances, and preparations containing them cannot exceed 30 days from the date of issuance. This is stipulated in Article 96a, paragraph 7, point 4 of the Pharmaceutical Law, in the consolidated text. Dz.U. 2026 poz. 612The information found in guides about fourteen days is false, and a patient planning a trip actually has two weeks more to fulfill the prescription than they think.

The scope of a single prescription is also limited. A prescription for preparations containing narcotic substances from group I-N and psychotropic substances from group II-P can cover a quantity corresponding to a maximum of 90 days of use, and a doctor can issue up to three such prescriptions for consecutive periods, totaling also up to 90 days of use. We describe in the text how the path to the first prescription looks in practice, how to become a medical marijuana patient.

Can a prescription for flower be obtained during a teleconsultation?

No, when it comes to the first prescription. Issuing a prescription for a preparation containing a narcotic substance requires prior personal examination of the patient by the person issuing the prescription when the prescribed preparation is listed in Annex 2 to the regulation on narcotic substances. In this annex, under items four and five, the herb of cannabis other than fiber and its extracts, as well as cannabis resin, are listed.

This requirement has one exception described in the regulation. It does not apply to a doctor providing services under a primary healthcare agreement, excluding night and holiday healthcare, if that doctor continues treatment with such a preparation. However, continuation is something different from starting therapy.

For someone planning a trip, this means that the weakest link in the schedule is often the visit, not the office. The 15 days to submit an application for the document must be added to the time for a personal visit, issuing the prescription, and its fulfillment at the pharmacy. A guide that directs to a prescription for dried cannabis via teleconsultation sends the reader for a document that the doctor, according to the regulation, should not issue in this form.

What are the consequences of transporting a drug without the required document?

The law names this action directly. Anyone who, contrary to the provisions of the law, brings in, exports, transports, acquires within the community, or supplies narcotic drugs or psychotropic substances is subject to a fine and imprisonment for up to 5 years. This is stated in Article 55, paragraph 1 of the Act on Counteracting Drug Addiction. In the case of lesser importance, paragraph 2 provides for a fine, restriction of liberty, or imprisonment for up to one year.

If the act involves a significant quantity or if the act was committed for the purpose of obtaining financial or personal benefits, Article 55, paragraph 3 provides for a fine and imprisonment of not less than three years. Article 62, which concerns possession itself, stands separately: up to 3 years in the basic type, from one year to 10 years for a significant quantity, and a milder penalty in the case of lesser importance.

Two things are worth remembering from this. First, transportation is a separate actionable act in the law, so having a prescription does not close the case if there is no document for transportation. Second, the limits of penalties are real and specified in the law, so there is no need to estimate them from guides. What a patient should have with them during a check in the country is described separately in the text about kontroli policyjnej a medycznej marihuanie.

Can you bring a drug purchased abroad?

Not based on a foreign prescription and not without a document. Bringing in is one of the actions listed in Article 55, paragraph 1, and the document allowing for import for personal medical needs is issued in Poland by the Chief Pharmaceutical Inspector, upon an application submitted no later than 15 days before crossing the border. A purchase at a pharmacy or sales point in another country does not replace this document.

The reverse direction works the same way. If you are returning to Poland with a drug obtained abroad, you need a document issued under § 6 to cross the border, just like when leaving. The regulation treats import and export under one norm and provides for both the same template from Annex 3.

This can be a surprise for those who purchased a product legally in a country where sales are allowed. The legality of the purchase at the place of purchase does not transfer to the legality of transport across the border, as these are two different actions described in two different legal orders. We outline practical procedures and a list of things to prepare separately in the text about how to transport medical marijuana abroad.

Why is a Polish document not sufficient in the destination country?

Because it is issued by a Polish authority and based on Polish law. The document from § 5 or § 6 determines that export or import on the Polish side is carried out in accordance with the regulations. It does not determine how the substance is classified by the law of the country you are going to, nor what its own requirements are. Within the European Union, the framework is set by a common certificate from the decision of the Executive Committee, but outside this framework, there is no common mechanism.

This is where the rule comes from, from which there is no shortcut. The regulations of the destination country are checked with its authorities: at the diplomatic mission of that country in Poland or with its authority responsible for drugs and controlled substances. Lists of friendly and restrictive countries, published in guides without citing legal acts, become outdated faster than the page on which they stand.

A separate risk is layovers. If the route leads through an airport in a third country, you are on its territory even if you do not leave the transit area, so its regulations may apply. This is a question for the authorities of the layover country, asked before purchasing the ticket, not after. We discuss the legal status in individual countries in a separate text about the legality of marijuana worldwide.

Does CBD oil fall under the same rules?

On the Polish side, no. Cannabidiol is not listed in the catalog of psychotropic substances, narcotic drugs, or new psychoactive substances, so a product containing it and not containing controlled substances is not subject to the procedure from the regulation on transport. Such a product does not require a document from § 5 or § 6.

However, the composition determines, not the trade name. Tetrahydrocannabinols remain controlled substances, and a hemp product containing them does not cease to be so just because the word oil appears on the label. If you are traveling with a hemp preparation, a document confirming the composition, such as a certificate of analysis of the batch, is valuable, as it answers the question of what is actually in the bottle.

Outside the EU, the situation looks different, and caution is warranted. Some countries do not distinguish hemp products based on the content of individual compounds and treat them collectively, so a declaration of no THC may not have legal significance there. As mentioned above: this is a question for the authorities of the destination country, not for the store that sold the product.

Can CBD replace medication during travel?

This is a question for the attending physician and only for them. Cannabidiol and tetrahydrocannabinol are separate compounds with distinct effects, and a prescription medication from cannabis herb has been prescribed to the patient for an indication that the article does not recognize. Switching the preparation for the duration of the trip is a therapeutic decision, not a logistical one, and it is made by the person conducting the treatment.

It is worth addressing the matter honestly, as the temptation is understandable. Traveling to a country with restrictive laws can be easier with an uncontrolled product than with a medication requiring documentation, and the formalities are eliminated. However, this does not mean that such a switch is therapeutically equivalent, and no regulation or any store page can decide this for the patient.

If the doctor considers the switch permissible, there remains the question of the destination country itself, described in the section above. If they believe that therapy should not be interrupted, a real option may be to change the direction of travel or its timing. Both answers are better than the scenario in which the patient stops treatment for two weeks and tells no one about it.

How to prepare the medication and documents for the trip?

The principle is simple: the medication travels in the packaging from the pharmacy, along with the document that pertains to it. The pharmacy packaging carries a label linking the preparation to a specific patient and a specific prescription, and this compliance is what is checked during a control. Transferring the contents to another container breaks this compliance and cannot be restored on site.

Keep the document from the inspectorate in your carry-on luggage, in a place accessible without unpacking your suitcase, and remember that when traveling outside the EU, you carry the original on paper, as the electronic copy remains with the issuing authority. It's also advisable to have a prescription and medical documentation, which you had to prepare for the application anyway. The storage conditions for the product are based on the pharmacy's recommendations provided on the packaging, and accessories help maintain them outside the home. przechowywania.

The last thing concerns behavior during inspections. Reporting the transport of a medication containing a controlled substance on your own initiative, along with presenting the document, is a simpler procedure than explaining yourself after the product is found in your luggage. If, despite the documents, the medication is seized, ask for written confirmation of this action and for contact with the consul of the Republic of Poland.

How to check on your own whether the regulation is still in force?

The easiest way is in the ELI register, maintained for Polish legal acts. The address is constructed according to a fixed pattern with the type of journal, year, and position, for example. eli.gov.pl/eli/DU/2026/827/ogl for the regulation discussed here. The register provides the title of the act, the date of publication, the date of entry into force, and the status, and the last field is what the reader checking a guide from a year ago is looking for.

There are two traps worth knowing before considering something confirmed. The first is the ISAP service, which in response to a query returns a placeholder with anti-bot protection for any identifier, even a fictitious one. The response code looks correct, although no one has seen the content of the act. The second is confusing the existence of an act with its applicability: an act may exist, have a correct number, and be long outdated because it has been replaced by a consolidated text or an amendment.

This gives rise to a simple rule for reading legal guides, including this one. If the text provides the act number, checking takes a minute and resolves the matter. If it only provides the name of the office, the number of days, or the percentage of patients without indicating the regulation or elaboration, there is nothing to check, and such information should not weigh in planning a trip with a controlled medication.

What does this text not resolve?

Three things, and it's better to say this directly than to leave the reader under the impression that they have everything. The first is the law of the destination country. We described Polish regulations because only they are available in the Polish Journal of Laws and only they can be checked by the given number. How the same substance is classified in Egypt, Japan, or the United Arab Emirates is determined by local law, and a credible answer is provided by the diplomatic mission of that country, not a Polish guide.

The second is the carrier's rules. An airline may have its own requirements for medications transported in carry-on luggage, independent of the law and the document from the inspectorate. These should be checked in the specific carrier's regulations before purchasing a ticket, as they change more often than legal acts and differ between airlines.

The third is your own medical situation. The article does not know what product you are taking, for what indication, and what other medications you are on, so it does not answer questions about dosing, interrupting therapy, or switching products. These are decisions made by the attending physician after a conversation, not based on a text on the internet. All this text can do is point out regulations and their numbers so that the conversation with the doctor and the office starts from the facts.

Where to start planning your trip?

From two questions asked in this order: where are you going and does that country belong to the European Union? The answer indicates the authority to which you direct your application and the attachment with the document template. Only then do you count the deadlines, remembering that 15 days before crossing the border is the latest deadline, not the target one.

The second step is a visit to the doctor, as it can be a bottleneck. The first prescription for a cannabis-based product requires a personal examination of the patient, and it must be filled within 30 days of issuance. The third step, parallel to the first two, is to inquire with the authorities of the destination country about their own requirements, as the Polish document does not replace them.

Finally, the most important thing for assessing risk. Transporting narcotics in violation of the law is a crime in Poland punishable by up to 5 years in prison, so the difference between a well-prepared trip and an unprepared one is not just about discomfort at the airport. All the regulations mentioned in this text have provided numbers, so each of them can be opened and read independently.

Frequently Asked Questions

Who issues the document for transporting medical marijuana abroad?

When traveling to a European Union country, the appropriate provincial pharmaceutical inspector issues it, and when traveling outside the Union, the Chief Pharmaceutical Inspector. This follows from § 5 and § 6 of the regulation of the Minister of Health of June 8, 2026, published as Dz.U. 2026 item 827.

How many days before departure must the application be submitted?

No later than 15 days before the day of crossing the border of the Republic of Poland. The same deadline applies to both paths, EU and non-EU. This is the latest deadline resulting from the regulation, not an estimate of the time for the office to process the case.

How long is such a document valid?

The document is issued for a specified period, not exceeding 30 days. This period is entered by the issuing authority. The regulation does not provide for the extension of the document nor does it contain a limit on the amount of the drug expressed in grams, as the amount results from the dosage specified on the prescription.

Is the Schengen certificate something different from a Polish document?

No, it is the same path. Article 75 of the Schengen Implementing Convention provides for the certificate, and its form was defined by the decision of the Executive Committee dated December 22, 1994. The Polish regulation requires issuing documents in accordance with the instructions from this decision and provides a template in the annex.

How long is a Polish prescription for hemp flower valid?

The validity period for prescriptions for narcotic drugs and psychotropic substances cannot exceed 30 days from the date of issuance, according to Article 96a, paragraph 7, point 4 of the Pharmaceutical Law. One prescription covers an amount corresponding to a maximum of 90 days of use.

What are the consequences of transporting a drug containing THC without documentation?

Transporting narcotic drugs in violation of the provisions of the law is subject to a fine and imprisonment for up to 5 years under Article 55, paragraph 1 of the Act on Counteracting Drug Addiction. In the case of lesser severity, the penalty is milder, and for a significant amount, it is no shorter than three years.

Does CBD oil require a certificate for travel?

On the Polish side, no, because cannabidiol is not listed in the register of controlled substances. However, the actual composition of the product is decisive, not the name on the label. Outside the EU, some countries do not distinguish hemp products by composition, so check with local authorities there.

Does a foreign prescription allow bringing a drug to Poland?

No. Importing is a separate action mentioned in Article 55, paragraph 1 of the Act, and the document allowing import for personal medical needs is issued by the Chief Pharmaceutical Inspector upon request submitted no later than 15 days before crossing the border.

The article is for informational and educational purposes and does not constitute legal advice. The legal status described in the article is valid as of the publication date: regulations regarding hemp may change. Before making a decision, consult a lawyer or current legal acts.

Author: Michał Waluk · Opublikowano: 2026-05-11 · Aktualizacja: 2026-08-10